Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Nausea × Gemcitabine × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 63 Carcinoma, Non-Small-Cell Lung 54 Breast Neoplasms 30 Nasopharyngeal Carcinoma 25 Lung Neoplasms 24 Urinary Bladder Neoplasms 21 Ovarian Neoplasms 17 Neoplasm Metastasis 17 Cholangiocarcinoma 14 Uterine Cervical Neoplasms 12 Lymphoma, Large B-Cell, Diffuse 12 Gallbladder Neoplasms 12 Biliary Tract Neoplasms 12 Triple Negative Breast Neoplasms 11 Neoplasms 11 Recurrence 10 Parkinson Disease 4, Autosomal Dominant Lewy Body 10 Non-Muscle Invasive Bladder Neoplasms 9 Carcinoma, Transitional Cell 9 Nasopharyngeal Neoplasms 7 Fallopian Tube Neoplasms 7 Carcinoma 7 Bile Duct Neoplasms 7 Lymphoma, Non-Hodgkin 6 Lymphoma 6 Adenocarcinoma 5 Urothelial Cancer 3 Neoplasms by Site 3 Lymphoma, T-Cell, Peripheral 3 Endocrine Gland Neoplasms 3

Interventions

Dexamethasone 12 Ondansetron 9 Granisetron 7 Palonosetron 5 Olanzapine 5 Aprepitant 5 casopitant 3 Radiotherapy 3 Prochlorperazine 2 Electroacupuncture 2 Analgesia 2 Acupressure 2 sinomenine 1 netupitant, palosentron drug combination 1 netupitant 1 lerisetron 1 fosaprepitant 1 dolasetron 1 dexamethasone acetate 1 Therapeutics 1 Thalidomide 1 Taxes 1 Surveys and Questionnaires 1 Sugars 1 Metoclopramide 1 Hygiene 1 Haloperidol 1 Gemcitabine 1 Exercise 1 Esomeprazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06017284 2023-11-24

PTCA199-5

Fudan University

Phase 3 Recruiting

Gastrointestinal

Nausea, Pancreatic Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡